Condor Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.31M | Buy |
62,402
+1,728
| +3% | +$119K | 0.37% | 64 |
|
|
2025
Q1 | $4.21M | Buy |
60,674
+828
| +1% | +$57.5K | 0.39% | 61 |
|
|
2024
Q4 | $5.15M | Buy |
59,846
+37,365
| +166% | +$3.21M | 0.45% | 50 |
|
|
2024
Q3 | $2.68M | Buy |
22,481
+164
| +0.7% | +$19.5K | 0.24% | 89 |
|
|
2024
Q2 | $3.19M | Sell |
22,317
-128
| -0.6% | -$18.3K | 0.3% | 75 |
|
|
2024
Q1 | $2.88M | Sell |
22,445
-193
| -0.9% | -$24.8K | 0.28% | 82 |
|
|
2023
Q4 | $2.34M | Sell |
22,638
-176
| -0.8% | -$18.2K | 0.25% | 91 |
|
|
2023
Q3 | $2.07M | Buy |
22,814
+62
| +0.3% | +$5.64K | 0.25% | 85 |
|
|
2023
Q2 | $1.84M | Sell |
22,752
-206
| -0.9% | -$16.7K | 0.22% | 99 |
|
|
2023
Q1 | $1.83M | Sell |
22,958
-130
| -0.6% | -$10.3K | 0.23% | 97 |
|
|
2022
Q4 | $1.56M | Buy |
+23,088
| New | +$1.56M | 0.2% | 110 |
|